Miriam Monge To Join Sartorius Stedim Biotech As Director Of Marketing For Integrated Solutions
Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, today announced the appointment of Miriam Monge as Director of Marketing for SSB’s Integrated Solutions unit.
WHITE PAPERS & CASE STUDIES
Continuous Biomanufacturing: 10 Reasons Sponsors Hesitate
By William Whitford, Sr. Manager, HyClone Cell Culture, GE Healthcare
The industry is abuzz with talk about continuous biomanufacturing (CB), and it virtues have been well described. Here we will look at some of the barriers or concerns perceived to limit its value to the industry. Justified or not, quite a few concerns have been expressed regarding the implementation of this new, rather disruptive technology.
Effect Of Sterilization On Mechanical Properties Of Silicone Rubbers
Silicone rubber is widely used in the pharmaceutical industry where sterilizability is an essential requirement for all fluid transfer equipment. Pharmaceutical products must be sterilized frequently and repeatedly by high level energy and/or chemical vapor in order to eliminate bacterial surface contamination.
Streamlining The Biological Factory: Making A Better CHO Cell For Biopharma Production
SAFC’s CHOZN® Platform has been developed as a ‘plug and play’ manufacturing system for the creation of biopharmaceutical producing cell lines.
Save Up To 8 Hours In Cell Line Development With ZFN Technology
Zinc finger nucleases (ZFNs) have proven to be a powerful tool for modifying genes. In comparison to traditional techniques, such as adding chemical or radiation based mutagens that cause various random mutations, ZFNs can create very accurate, targeted changes to the genome in a much more rapid fashion.
Is Your Single-Use System Supplier Disposable?
During the last six years, single-use systems and devices have emerged as key agents in the biopharmaceutical landscape. By John Briggs, ASQ, CQA, Quality Assurance Manager - ASI
Meeting BioPharma Needs For Lower Operating Cost And Faster Time To Market
Broad adoption awaits fully scalable GMP systems, improved and less costly disposables, better analytics, greater process automation and low-shear mixing.